HEADER TRANSFERASE, HYDROLASE/INHIBITOR 11-JUL-12 4G1Q TITLE CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TITLE 2 RILPIVIRINE (TMC278, EDURANT), A NON-NUCLEOSIDE RT-INHIBITING DRUG COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: P66, UNP RESIDUES 600-1154; COMPND 5 SYNONYM: EXORIBONUCLEASE H, P66 RT; COMPND 6 EC: 2.7.7.49, 2.7.7.7, 3.1.26.13; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: P51 RT; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: P51, UNP RESIDUES 600-1027; COMPND 13 EC: 2.7.7.49, 2.7.7.7, 3.1.26.13; COMPND 14 ENGINEERED: YES; COMPND 15 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 11678; SOURCE 5 STRAIN: BH10 ISOLATE; SOURCE 6 GENE: GAG-POL; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRT52A; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; SOURCE 13 ORGANISM_COMMON: HIV-1; SOURCE 14 ORGANISM_TAXID: 11678; SOURCE 15 STRAIN: BH10 ISOLATE; SOURCE 16 GENE: GAG-POL; SOURCE 17 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PRT52A KEYWDS P51/P66, HETERO DIMER, NNRTI, NONNUCLEOSIDE INHIBITOR, AIDS, HIV, KEYWDS 2 R278474, DIARYLPYRIMIDINE, DAPY, DNA RECOMBINATION, RNA-DIRECTED DNA KEYWDS 3 POLYMERASE, DNA POLYMERASE, ENDONUCLEASE, HYDROLASE, MULTIFUNCTIONAL KEYWDS 4 ENZYME, TRANSFERASE, HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.D.BAUMAN,D.PATEL,K.DAS,E.ARNOLD REVDAT 5 13-SEP-23 4G1Q 1 REMARK SEQADV LINK REVDAT 4 24-JAN-18 4G1Q 1 AUTHOR REVDAT 3 17-JUN-15 4G1Q 1 HETSYN REVDAT 2 06-MAR-13 4G1Q 1 JRNL REVDAT 1 06-FEB-13 4G1Q 0 JRNL AUTH D.G.KURODA,J.D.BAUMAN,J.R.CHALLA,D.PATEL,T.TROXLER,K.DAS, JRNL AUTH 2 E.ARNOLD,R.M.HOCHSTRASSER JRNL TITL SNAPSHOT OF THE EQUILIBRIUM DYNAMICS OF A DRUG BOUND TO JRNL TITL 2 HIV-1 REVERSE TRANSCRIPTASE. JRNL REF NAT CHEM V. 5 174 2013 JRNL REFN ESSN 1755-4349 JRNL PMID 23422558 JRNL DOI 10.1038/NCHEM.1559 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.DAS,J.D.BAUMAN,A.D.CLARK,Y.V.FRENKEL,P.J.LEWI,A.J.SHATKIN, REMARK 1 AUTH 2 S.H.HUGHES,E.ARNOLD REMARK 1 TITL HIGH-RESOLUTION STRUCTURES OF HIV-1 REVERSE REMARK 1 TITL 2 TRANSCRIPTASE/TMC278 COMPLEXES: STRATEGIC FLEXIBILITY REMARK 1 TITL 3 EXPLAINS POTENCY AGAINST RESISTANCE MUTATIONS. REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 105 1466 2008 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 18230722 REMARK 1 DOI 10.1073/PNAS.0711209105 REMARK 1 REFERENCE 2 REMARK 1 AUTH K.DAS,S.E.MARTINEZ,J.D.BAUMAN,E.ARNOLD REMARK 1 TITL HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND NEVIRAPINE REMARK 1 TITL 2 REVEALS NON-NUCLEOSIDE INHIBITION MECHANISM. REMARK 1 REF NAT.STRUCT.MOL.BIOL. V. 19 253 2012 REMARK 1 REFN ISSN 1545-9993 REMARK 1 PMID 22266819 REMARK 1 DOI 10.1038/NSMB.2223 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.D.BAUMAN,K.DAS,W.C.HO,M.BAWEJA,D.M.HIMMEL,A.D.CLARK, REMARK 1 AUTH 2 D.A.OREN,P.L.BOYER,S.H.HUGHES,A.J.SHATKIN,E.ARNOLD REMARK 1 TITL CRYSTAL ENGINEERING OF HIV-1 REVERSE TRANSCRIPTASE FOR REMARK 1 TITL 2 STRUCTURE-BASED DRUG DESIGN. REMARK 1 REF NUCLEIC ACIDS RES. V. 36 5083 2008 REMARK 1 REFN ISSN 0305-1048 REMARK 1 PMID 18676450 REMARK 1 DOI 10.1093/NAR/GKN464 REMARK 1 REFERENCE 4 REMARK 1 AUTH K.DAS,S.G.SARAFIANOS,A.D.CLARK,P.L.BOYER,S.H.HUGHES,E.ARNOLD REMARK 1 TITL CRYSTAL STRUCTURES OF CLINICALLY RELEVANT REMARK 1 TITL 2 LYS103ASN/TYR181CYS DOUBLE MUTANT HIV-1 REVERSE REMARK 1 TITL 3 TRANSCRIPTASE IN COMPLEXES WITH ATP AND NON-NUCLEOSIDE REMARK 1 TITL 4 INHIBITOR HBY 097. REMARK 1 REF J.MOL.BIOL. V. 365 77 2007 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 17056061 REMARK 1 DOI 10.1016/J.JMB.2006.08.097 REMARK 1 REFERENCE 5 REMARK 1 AUTH K.DAS,A.D.CLARK,P.J.LEWI,J.HEERES,M.R.DE JONGE,L.M.KOYMANS, REMARK 1 AUTH 2 H.M.VINKERS,F.DAEYAERT,D.W.LUDOVICI,M.J.KUKLA,B.DE CORTE, REMARK 1 AUTH 3 R.W.KAVASH,C.Y.HO,H.YE,M.A.LICHTENSTEIN,K.ANDRIES,R.PAUWELS, REMARK 1 AUTH 4 M.P.DE BETHUNE,P.L.BOYER,P.CLARK,S.H.HUGHES,P.A.JANSSEN, REMARK 1 AUTH 5 E.ARNOLD REMARK 1 TITL ROLES OF CONFORMATIONAL AND POSITIONAL ADAPTABILITY IN REMARK 1 TITL 2 STRUCTURE-BASED DESIGN OF TMC125-R165335 (ETRAVIRINE) AND REMARK 1 TITL 3 RELATED NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS THAT REMARK 1 TITL 4 ARE HIGHLY POTENT AND EFFECTIVE AGAINST WILD-TYPE AND REMARK 1 TITL 5 DRUG-RESISTANT HIV-1 VARIANTS. REMARK 1 REF J.MED.CHEM. V. 47 2550 2004 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 15115397 REMARK 1 DOI 10.1021/JM030558S REMARK 2 REMARK 2 RESOLUTION. 1.51 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7.3_928) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.51 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.85 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 190062 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.155 REMARK 3 R VALUE (WORKING SET) : 0.154 REMARK 3 FREE R VALUE : 0.193 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.020 REMARK 3 FREE R VALUE TEST SET COUNT : 3833 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.8630 - 4.5271 0.97 7117 142 0.2005 0.2369 REMARK 3 2 4.5271 - 3.5944 0.99 7159 151 0.1539 0.1872 REMARK 3 3 3.5944 - 3.1403 1.00 7136 148 0.1604 0.1865 REMARK 3 4 3.1403 - 2.8533 1.00 7168 151 0.1514 0.1768 REMARK 3 5 2.8533 - 2.6489 1.00 7109 166 0.1468 0.1645 REMARK 3 6 2.6489 - 2.4927 1.00 7093 150 0.1391 0.2006 REMARK 3 7 2.4927 - 2.3679 1.00 7134 145 0.1315 0.1868 REMARK 3 8 2.3679 - 2.2649 1.00 7059 148 0.1245 0.1659 REMARK 3 9 2.2649 - 2.1777 1.00 7117 133 0.1191 0.1773 REMARK 3 10 2.1777 - 2.1026 0.99 7067 158 0.1186 0.1685 REMARK 3 11 2.1026 - 2.0368 0.99 6976 137 0.1155 0.1454 REMARK 3 12 2.0368 - 1.9786 0.97 6904 150 0.1155 0.1568 REMARK 3 13 1.9786 - 1.9265 0.96 6847 119 0.1108 0.1829 REMARK 3 14 1.9265 - 1.8795 0.96 6784 149 0.1082 0.1588 REMARK 3 15 1.8795 - 1.8368 0.96 6751 142 0.1118 0.1625 REMARK 3 16 1.8368 - 1.7977 0.96 6806 135 0.1189 0.1644 REMARK 3 17 1.7977 - 1.7617 0.95 6781 123 0.1276 0.2120 REMARK 3 18 1.7617 - 1.7285 0.96 6762 138 0.1340 0.1844 REMARK 3 19 1.7285 - 1.6976 0.95 6720 146 0.1422 0.1847 REMARK 3 20 1.6976 - 1.6689 0.95 6784 142 0.1584 0.2324 REMARK 3 21 1.6689 - 1.6419 0.96 6727 131 0.1747 0.2543 REMARK 3 22 1.6419 - 1.6167 0.95 6770 116 0.1899 0.2383 REMARK 3 23 1.6167 - 1.5929 0.95 6747 124 0.2031 0.2581 REMARK 3 24 1.5929 - 1.5705 0.95 6728 157 0.2220 0.2567 REMARK 3 25 1.5705 - 1.5492 0.95 6735 145 0.2462 0.2856 REMARK 3 26 1.5492 - 1.5291 0.94 6648 140 0.2727 0.3184 REMARK 3 27 1.5291 - 1.5100 0.94 6600 147 0.3027 0.3573 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.98 REMARK 3 K_SOL : 0.40 REMARK 3 B_SOL : 69.97 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.600 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.07830 REMARK 3 B22 (A**2) : -2.36320 REMARK 3 B33 (A**2) : 1.28480 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -3.29850 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.013 8280 REMARK 3 ANGLE : 1.362 11254 REMARK 3 CHIRALITY : 0.080 1211 REMARK 3 PLANARITY : 0.008 1413 REMARK 3 DIHEDRAL : 14.162 3136 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4G1Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JUL-12. REMARK 100 THE DEPOSITION ID IS D_1000073627. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-OCT-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 193097 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.79700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 2ZD1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, AMMONIUM SULFATE, REMARK 280 MGCL2,IMIDAZOLE, PH 6.8, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 81.35650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.25850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 81.35650 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 36.25850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 47100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 555 REMARK 465 PRO B 1 REMARK 465 ILE B 2 REMARK 465 SER B 3 REMARK 465 PRO B 4 REMARK 465 THR B 216 REMARK 465 PRO B 217 REMARK 465 ASP B 218 REMARK 465 LYS B 219 REMARK 465 LYS B 220 REMARK 465 HIS B 221 REMARK 465 GLN B 222 REMARK 465 LYS B 223 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU B 224 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HE22 GLN A 373 HG1 THR B 397 1.12 REMARK 500 NE2 GLN A 373 HG1 THR B 397 1.54 REMARK 500 HZ2 LYS B 30 O HOH B 839 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET B 357 CB - CG - SD ANGL. DEV. = 22.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 66 148.67 -38.90 REMARK 500 MET A 184 -129.29 57.13 REMARK 500 LYS A 219 106.44 -51.13 REMARK 500 HIS A 221 151.04 -50.00 REMARK 500 ILE A 270 -25.13 -141.95 REMARK 500 GLN B 85 156.57 -45.39 REMARK 500 ASN B 136 19.43 57.71 REMARK 500 MET B 184 -119.01 52.09 REMARK 500 ARG B 356 37.70 -95.71 REMARK 500 ALA B 360 35.68 -140.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 608 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 443 OD2 REMARK 620 2 ASP A 549 OD1 94.1 REMARK 620 3 HOH A1092 O 89.1 174.0 REMARK 620 4 HOH A1130 O 84.9 98.1 87.2 REMARK 620 5 HOH A1131 O 90.9 88.7 86.2 172.2 REMARK 620 6 HOH A1155 O 175.5 89.7 87.3 92.3 91.5 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE T27 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 605 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 606 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 607 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 608 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 505 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1S6Q RELATED DB: PDB REMARK 900 RELATED ID: 1SV5 RELATED DB: PDB REMARK 900 RELATED ID: 2IC3 RELATED DB: PDB REMARK 900 RELATED ID: 2ZD1 RELATED DB: PDB REMARK 900 RELATED ID: 2ZE2 RELATED DB: PDB REMARK 900 RELATED ID: 3BGR RELATED DB: PDB REMARK 900 RELATED ID: 3DLK RELATED DB: PDB REMARK 900 RELATED ID: 3V81 RELATED DB: PDB DBREF 4G1Q A 1 555 UNP P03366 POL_HV1B1 600 1154 DBREF 4G1Q B 1 428 UNP P03366 POL_HV1B1 600 1027 SEQADV 4G1Q MET A -1 UNP P03366 EXPRESSION TAG SEQADV 4G1Q VAL A 0 UNP P03366 EXPRESSION TAG SEQADV 4G1Q ALA A 172 UNP P03366 LYS 771 ENGINEERED MUTATION SEQADV 4G1Q ALA A 173 UNP P03366 LYS 772 ENGINEERED MUTATION SEQADV 4G1Q SER A 280 UNP P03366 CYS 879 ENGINEERED MUTATION SEQADV 4G1Q SER B 280 UNP P03366 CYS 879 ENGINEERED MUTATION SEQRES 1 A 557 MET VAL PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS SEQRES 2 A 557 LEU LYS PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP SEQRES 3 A 557 PRO LEU THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE SEQRES 4 A 557 CYS THR GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE SEQRES 5 A 557 GLY PRO GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE SEQRES 6 A 557 LYS LYS LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP SEQRES 7 A 557 PHE ARG GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU SEQRES 8 A 557 VAL GLN LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS SEQRES 9 A 557 LYS LYS SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR SEQRES 10 A 557 PHE SER VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR SEQRES 11 A 557 ALA PHE THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY SEQRES 12 A 557 ILE ARG TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS SEQRES 13 A 557 GLY SER PRO ALA ILE PHE GLN SER SER MET THR LYS ILE SEQRES 14 A 557 LEU GLU PRO PHE ALA ALA GLN ASN PRO ASP ILE VAL ILE SEQRES 15 A 557 TYR GLN TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU SEQRES 16 A 557 GLU ILE GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG SEQRES 17 A 557 GLN HIS LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS SEQRES 18 A 557 LYS HIS GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR SEQRES 19 A 557 GLU LEU HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL SEQRES 20 A 557 LEU PRO GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN SEQRES 21 A 557 LYS LEU VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR SEQRES 22 A 557 PRO GLY ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG SEQRES 23 A 557 GLY THR LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU SEQRES 24 A 557 GLU ALA GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU SEQRES 25 A 557 LYS GLU PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS SEQRES 26 A 557 ASP LEU ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN SEQRES 27 A 557 TRP THR TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU SEQRES 28 A 557 LYS THR GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR SEQRES 29 A 557 ASN ASP VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE SEQRES 30 A 557 THR THR GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS SEQRES 31 A 557 PHE LYS LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP SEQRES 32 A 557 TRP THR GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP SEQRES 33 A 557 GLU PHE VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR SEQRES 34 A 557 GLN LEU GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE SEQRES 35 A 557 TYR VAL ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY SEQRES 36 A 557 LYS ALA GLY TYR VAL THR ASN LYS GLY ARG GLN LYS VAL SEQRES 37 A 557 VAL PRO LEU THR ASN THR THR ASN GLN LYS THR GLU LEU SEQRES 38 A 557 GLN ALA ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU SEQRES 39 A 557 VAL ASN ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE SEQRES 40 A 557 ILE GLN ALA GLN PRO ASP LYS SER GLU SER GLU LEU VAL SEQRES 41 A 557 ASN GLN ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL SEQRES 42 A 557 TYR LEU ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY SEQRES 43 A 557 ASN GLU GLN VAL ASP LYS LEU VAL SER ALA GLY SEQRES 1 B 428 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 428 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 428 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 428 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 428 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 428 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 428 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 428 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 428 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 428 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 428 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 428 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 428 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 428 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 428 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 428 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 428 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 428 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 428 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 428 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 428 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 428 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 B 428 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 428 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 428 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 428 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 428 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 428 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 428 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 428 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 428 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 428 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 428 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN HET T27 A 601 46 HET SO4 A 602 5 HET SO4 A 603 5 HET SO4 A 604 5 HET SO4 A 605 5 HET EDO A 606 4 HET EDO A 607 4 HET MG A 608 1 HET SO4 B 501 5 HET SO4 B 502 5 HET EDO B 503 4 HET EDO B 504 4 HET EDO B 505 4 HETNAM T27 4-{[4-({4-[(E)-2-CYANOETHENYL]-2,6- HETNAM 2 T27 DIMETHYLPHENYL}AMINO)PYRIMIDIN-2-YL]AMINO}BENZONITRILE HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETNAM MG MAGNESIUM ION HETSYN T27 RILPIVIRINE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 T27 C22 H18 N6 FORMUL 4 SO4 6(O4 S 2-) FORMUL 8 EDO 5(C2 H6 O2) FORMUL 10 MG MG 2+ FORMUL 16 HOH *824(H2 O) HELIX 1 1 THR A 27 GLU A 44 1 18 HELIX 2 2 PHE A 77 THR A 84 1 8 HELIX 3 3 HIS A 96 LEU A 100 5 5 HELIX 4 4 ASP A 113 VAL A 118 5 6 HELIX 5 5 ASP A 121 ALA A 129 5 9 HELIX 6 6 SER A 134 GLU A 138 5 5 HELIX 7 7 GLY A 155 ASN A 175 1 21 HELIX 8 8 GLU A 194 LEU A 210 1 17 HELIX 9 9 ARG A 211 GLY A 213 5 3 HELIX 10 10 THR A 253 SER A 268 1 16 HELIX 11 11 VAL A 276 LYS A 281 1 6 HELIX 12 12 LEU A 282 ARG A 284 5 3 HELIX 13 13 THR A 296 LEU A 310 1 15 HELIX 14 14 ASN A 363 GLY A 384 1 22 HELIX 15 15 GLN A 394 TYR A 405 1 12 HELIX 16 16 THR A 473 SER A 489 1 17 HELIX 17 17 SER A 499 GLN A 507 1 9 HELIX 18 18 SER A 515 LYS A 528 1 14 HELIX 19 19 GLY A 544 ALA A 554 1 11 HELIX 20 20 THR B 27 GLU B 44 1 18 HELIX 21 21 PHE B 77 THR B 84 1 8 HELIX 22 22 GLY B 99 LYS B 103 5 5 HELIX 23 23 GLY B 112 VAL B 118 5 7 HELIX 24 24 PHE B 124 ALA B 129 5 6 HELIX 25 25 SER B 134 GLU B 138 5 5 HELIX 26 26 LYS B 154 ASN B 175 1 22 HELIX 27 27 GLU B 194 LEU B 214 1 21 HELIX 28 28 HIS B 235 TRP B 239 5 5 HELIX 29 29 THR B 253 SER B 268 1 16 HELIX 30 30 VAL B 276 LYS B 281 1 6 HELIX 31 31 LEU B 282 ARG B 284 5 3 HELIX 32 32 THR B 296 LEU B 310 1 15 HELIX 33 33 ASN B 363 GLY B 384 1 22 HELIX 34 34 GLN B 394 TRP B 406 1 13 HELIX 35 35 VAL B 423 GLN B 428 1 6 SHEET 1 A 3 ILE A 47 LYS A 49 0 SHEET 2 A 3 ILE A 142 TYR A 146 -1 O GLN A 145 N SER A 48 SHEET 3 A 3 PHE A 130 ILE A 132 -1 N ILE A 132 O ILE A 142 SHEET 1 B 2 VAL A 60 LYS A 64 0 SHEET 2 B 2 TRP A 71 VAL A 75 -1 O ARG A 72 N ILE A 63 SHEET 1 C 3 SER A 105 ASP A 110 0 SHEET 2 C 3 ASP A 186 SER A 191 -1 O LEU A 187 N LEU A 109 SHEET 3 C 3 ILE A 178 TYR A 183 -1 N TYR A 181 O TYR A 188 SHEET 1 D 3 PHE A 227 TRP A 229 0 SHEET 2 D 3 TYR A 232 LEU A 234 -1 O LEU A 234 N PHE A 227 SHEET 3 D 3 TRP A 239 VAL A 241 -1 O THR A 240 N GLU A 233 SHEET 1 E 5 LYS A 347 ALA A 355 0 SHEET 2 E 5 GLN A 336 GLU A 344 -1 N ILE A 341 O LYS A 350 SHEET 3 E 5 ILE A 326 GLY A 333 -1 N GLN A 332 O GLN A 336 SHEET 4 E 5 LYS A 388 LEU A 391 1 O LYS A 388 N ALA A 327 SHEET 5 E 5 TRP A 414 PHE A 416 1 O GLU A 415 N LEU A 391 SHEET 1 F 2 HIS A 361 THR A 362 0 SHEET 2 F 2 LYS A 512 SER A 513 -1 O LYS A 512 N THR A 362 SHEET 1 G 5 GLN A 464 LEU A 469 0 SHEET 2 G 5 GLY A 453 THR A 459 -1 N ALA A 455 O VAL A 467 SHEET 3 G 5 GLU A 438 ALA A 446 -1 N TYR A 441 O VAL A 458 SHEET 4 G 5 GLU A 492 THR A 497 1 O ASN A 494 N PHE A 440 SHEET 5 G 5 LYS A 530 TRP A 535 1 O ALA A 534 N ILE A 495 SHEET 1 H 3 ILE B 47 LYS B 49 0 SHEET 2 H 3 ILE B 142 TYR B 146 -1 O GLN B 145 N SER B 48 SHEET 3 H 3 PHE B 130 ILE B 132 -1 N ILE B 132 O ILE B 142 SHEET 1 I 2 VAL B 60 ILE B 63 0 SHEET 2 I 2 ARG B 72 VAL B 75 -1 O ARG B 72 N ILE B 63 SHEET 1 J 4 VAL B 179 TYR B 183 0 SHEET 2 J 4 ASP B 186 SER B 191 -1 O TYR B 188 N TYR B 181 SHEET 3 J 4 SER B 105 ASP B 110 -1 N LEU B 109 O LEU B 187 SHEET 4 J 4 TYR B 232 LEU B 234 -1 O LEU B 234 N VAL B 106 SHEET 1 K 5 ASN B 348 TYR B 354 0 SHEET 2 K 5 GLN B 336 TYR B 342 -1 N ILE B 341 O LEU B 349 SHEET 3 K 5 ILE B 326 GLY B 333 -1 N ILE B 326 O TYR B 342 SHEET 4 K 5 LYS B 388 LEU B 391 1 O LYS B 390 N ALA B 327 SHEET 5 K 5 GLU B 413 PHE B 416 1 O GLU B 415 N LEU B 391 LINK OD2 ASP A 443 MG MG A 608 1555 1555 2.24 LINK OD1 ASP A 549 MG MG A 608 1555 1555 2.03 LINK MG MG A 608 O HOH A1092 1555 1555 2.29 LINK MG MG A 608 O HOH A1130 1555 1555 2.09 LINK MG MG A 608 O HOH A1131 1555 1555 2.15 LINK MG MG A 608 O HOH A1155 1555 1555 2.17 CISPEP 1 PRO A 225 PRO A 226 0 -0.89 CISPEP 2 PRO A 420 PRO A 421 0 2.28 SITE 1 AC1 13 LEU A 100 LYS A 101 TYR A 181 TYR A 188 SITE 2 AC1 13 PRO A 225 PHE A 227 TRP A 229 LEU A 234 SITE 3 AC1 13 HIS A 235 PRO A 236 TYR A 318 HOH A 863 SITE 4 AC1 13 HOH B 724 SITE 1 AC2 7 MET A 41 LYS A 73 TYR A 146 PRO A 150 SITE 2 AC2 7 GLN A 151 HOH A 815 HOH A1147 SITE 1 AC3 6 LYS A 331 GLY A 333 GLN A 334 LYS A 512 SITE 2 AC3 6 HOH A 824 HOH A1033 SITE 1 AC4 6 ARG A 277 GLN A 278 LYS A 281 GLN A 334 SITE 2 AC4 6 ARG A 356 HOH A1070 SITE 1 AC5 5 LYS A 476 SER A 515 GLU A 516 LEU A 517 SITE 2 AC5 5 HOH A1185 SITE 1 AC6 5 LEU A 425 TRP A 426 TYR A 427 GLN A 509 SITE 2 AC6 5 HOH A 895 SITE 1 AC7 6 GLU A 6 VAL A 8 SER A 162 SER A 163 SITE 2 AC7 6 HOH A 715 PRO B 52 SITE 1 AC8 6 ASP A 443 ASP A 549 HOH A1092 HOH A1130 SITE 2 AC8 6 HOH A1131 HOH A1155 SITE 1 AC9 3 LEU B 234 HIS B 235 TRP B 239 SITE 1 BC1 8 THR A 403 GLU A 404 TYR A 405 LYS B 331 SITE 2 BC1 8 GLN B 332 LYS B 424 HOH B 834 HOH B 913 SITE 1 BC2 4 TRP B 24 GLU B 399 TRP B 402 HOH B 817 SITE 1 BC3 7 ILE B 31 ILE B 132 PRO B 133 SER B 134 SITE 2 BC3 7 ILE B 142 HOH B 625 HOH B 636 SITE 1 BC4 7 LYS B 65 VAL B 108 ASP B 186 HOH B 681 SITE 2 BC4 7 HOH B 694 HOH B 721 HOH B 865 CRYST1 162.713 72.517 109.514 90.00 100.84 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006146 0.000000 0.001177 0.00000 SCALE2 0.000000 0.013790 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009297 0.00000